Pulsesight reports positive phase 1 data for PST611 in dry AMD

PharmaTimes

Early safety and efficacy signals support move into repeatdose phase 2a trial

pharminent May 11, 2026 (Last updated: May 11, 2026)

PharmaTimes

Early safety and efficacy signals support move into repeatdose phase 2a trial

Related Stories